The U.S. Supreme Court rejected review of a Second Circuit decision regarding a group of researchers alleging that Illumina Inc. and others misused their trade secrets in patent applications.
The researchers waited too long to bring claims against Illumina, the U.S. Court of Appeals for the Second Circuit ruled in December 2020, affirming a Manhattan federal court decision. The circuit court said the researchers should have been aware of earlier public proceedings, adding that the statute of limitations had run out.
The four researchers collaborated with Cornell University to invent a new method for diagnosing human genetics defects involving ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.